Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh. more
Time Frame | DXR | Sector | S&P500 |
---|---|---|---|
1-Week Return | -5.46% | -1.57% | 0.77% |
1-Month Return | -2.31% | -1.86% | 5.21% |
3-Month Return | -4.17% | -6.07% | 10.43% |
6-Month Return | 5.21% | -0.47% | 13.46% |
1-Year Return | 13.7% | 10% | 32.91% |
3-Year Return | -15.96% | 10.67% | 32.22% |
5-Year Return | -5.5% | 45.46% | 94.57% |
10-Year Return | 32.82% | 104.97% | 192.3% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | (114.99K) | (996.30K) | 5.82M | 6.31M | 1.28M | [{"date":"2019-12-31","value":-1.82,"profit":false},{"date":"2020-12-31","value":-15.79,"profit":false},{"date":"2021-12-31","value":92.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.29,"profit":true}] |
Cost of Revenue | 488.65K | 562.83K | 1.00M | 1.09M | 1.12M | [{"date":"2019-12-31","value":43.74,"profit":true},{"date":"2020-12-31","value":50.38,"profit":true},{"date":"2021-12-31","value":89.65,"profit":true},{"date":"2022-12-31","value":97.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (114.99K) | (996.30K) | 5.82M | 6.31M | 163.42K | [{"date":"2019-12-31","value":-1.82,"profit":false},{"date":"2020-12-31","value":-15.79,"profit":false},{"date":"2021-12-31","value":92.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.59,"profit":true}] |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 12.76% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":12.76,"profit":true}] |
Operating Expenses | 380.70K | 734.37K | 1.07M | 1.13M | 1.28M | [{"date":"2019-12-31","value":29.73,"profit":true},{"date":"2020-12-31","value":57.35,"profit":true},{"date":"2021-12-31","value":83.79,"profit":true},{"date":"2022-12-31","value":88.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (495.70K) | (1.73M) | 4.75M | 5.25M | (177.07K) | [{"date":"2019-12-31","value":-9.44,"profit":false},{"date":"2020-12-31","value":-32.96,"profit":false},{"date":"2021-12-31","value":90.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3.37,"profit":false}] |
Total Non-Operating Income/Expense | (286.97K) | (16.80K) | (39.21K) | (144.91K) | 408.61K | [{"date":"2019-12-31","value":-70.23,"profit":false},{"date":"2020-12-31","value":-4.11,"profit":false},{"date":"2021-12-31","value":-9.6,"profit":false},{"date":"2022-12-31","value":-35.46,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (495.70K) | (1.73M) | 4.75M | 5.18M | 280.64K | [{"date":"2019-12-31","value":-9.57,"profit":false},{"date":"2020-12-31","value":-33.42,"profit":false},{"date":"2021-12-31","value":91.7,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.42,"profit":true}] |
Income Taxes | (122.05K) | (25.28K) | (765.18K) | (859.73K) | (788.04K) | [{"date":"2019-12-31","value":-12204700,"profit":false},{"date":"2020-12-31","value":-2528000,"profit":false},{"date":"2021-12-31","value":-76518000,"profit":false},{"date":"2022-12-31","value":-85973300,"profit":false},{"date":"2023-12-31","value":-78804400,"profit":false}] |
Income After Taxes | (373.65K) | (1.71M) | 5.51M | 6.04M | 1.07M | [{"date":"2019-12-31","value":-6.19,"profit":false},{"date":"2020-12-31","value":-28.24,"profit":false},{"date":"2021-12-31","value":91.31,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":17.7,"profit":true}] |
Income From Continuous Operations | (495.70K) | (1.71M) | 4.75M | 5.18M | 280.64K | [{"date":"2019-12-31","value":-9.57,"profit":false},{"date":"2020-12-31","value":-32.93,"profit":false},{"date":"2021-12-31","value":91.7,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.42,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (495.70K) | (1.71M) | 4.75M | 5.18M | 280.64K | [{"date":"2019-12-31","value":-9.57,"profit":false},{"date":"2020-12-31","value":-32.93,"profit":false},{"date":"2021-12-31","value":91.7,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.42,"profit":true}] |
EPS (Diluted) | (0.26) | (0.68) | 0.99 | 1.09 | - | [{"date":"2019-12-31","value":-24.25,"profit":false},{"date":"2020-12-31","value":-62.18,"profit":false},{"date":"2021-12-31","value":90.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
DXR | |
---|---|
Current Ratio | 0.28 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
DXR | |
---|---|
ROA (LTM) | -1.40% |
ROE (LTM) | 5.35% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
DXR | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.05 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.95 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
DXR | |
---|---|
Trailing PE | 7.83 |
Forward PE | NM |
P/S (TTM) | 285.15 |
P/B | 1.35 |
Price/FCF | NM |
EV/R | 17.51 |
EV/Ebitda | NM |
PEG | NM |
Daxor Corporation (DXR) share price today is $9.045
Yes, Indians can buy shares of Daxor Corporation (DXR) on Vested. To buy Daxor Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DXR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Daxor Corporation (DXR) via the Vested app. You can start investing in Daxor Corporation (DXR) with a minimum investment of $1.
You can invest in shares of Daxor Corporation (DXR) via Vested in three simple steps:
The 52-week high price of Daxor Corporation (DXR) is $10.04. The 52-week low price of Daxor Corporation (DXR) is $7.16.
The price-to-earnings (P/E) ratio of Daxor Corporation (DXR) is 7.8319
The price-to-book (P/B) ratio of Daxor Corporation (DXR) is 1.35
The dividend yield of Daxor Corporation (DXR) is 0.00%
The market capitalization of Daxor Corporation (DXR) is $43.97M
The stock symbol (or ticker) of Daxor Corporation is DXR